low-grade b-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... agbay et al, am j surg...
TRANSCRIPT
![Page 1: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/1.jpg)
Pathology Stephan Dirnhofer
Low-grade B-cell lymphoma
Patho-Basic 11. September 2018
![Page 2: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/2.jpg)
• Definition
• LPL, MBL/CLL/SLL, MCL
• FL
Subtypes & variants
Diagnosis including Grading
Transformation
• Summary
Outline
![Page 3: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/3.jpg)
Be aware - in Lymphoma
aggressive vs indolent
high grade versus low grade
large cell versus small cell
… does not mean the same!
![Page 4: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/4.jpg)
• No grading in lymphoma
• Exception: Follicular Lymphoma (FL)
• «low grade lymphoma» does not exist
• synonymous with «cytic» or «small cell», but cave: MCL, etc
• Clinical approach: «indolent» vs «aggressive»
• Pathological approach: «small lymphoid B-cell neoplams»
• «High-grade B-cell lymphoma»: specific category in WHO2017
– NOS
– DH/TH
Definition
![Page 5: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/5.jpg)
Lymphoplasmacytic lymphoma (LPL)/WM
• MYD88 L265P in >95% LPL
• MGUS, IgM in 50-80%
• PCM, MGUS, IgA & IgG negative
• Very rare in other SBCL (<5%)
• DLBCL: 10-30%, adverse prognosis
• Predictive biomarker
• Ibrutinib sensitive
2016
2012
2015
![Page 6: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/6.jpg)
SLL/CLL: diffuse/pseudofollicular
![Page 7: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/7.jpg)
CD23 CD5 CD3 CD20
SLL/CLL: Phenotype
![Page 8: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/8.jpg)
• Definition
Monoclonal PB lymphocyte populations up to 5x109/L either with the
phenotype of CLL, atypical CLL (CD5+, bright CD20, some include
CD23-) or non-CLL (CD5-) in the absence of lymphomatous features.
MBL population has to be present for at least 3 months
• MBL, CLL‐type
Distinguish “low count” (<0.5) from “high count” MBL
• MBL, non CLL‐type
Related to (splenic) marginal zone lymphoma
Monoclonal B‐cell lymphocytosis (MBL)
Xochelli, Blood, 2014
Bruscaggin, BJH, 2014
WHO, 2017
![Page 9: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/9.jpg)
• Same phenotype
• Similar genotype
• Distinguish “low count” (<0.5) from “high count” MBL
• “low count MBL”: limited, if any, risk of progression
• “high count” MBL: routine (yearly) follow up
• Eliminate CLL Dx if < 5x109/L & cytopenia without extramedullary disease
MBL, CLL-type and CLL
Giné, Haematologica, 2010
Bullan, JCO 2014
![Page 10: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/10.jpg)
Mantle cell lymphoma (MCL): diffuse/nodular
![Page 11: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/11.jpg)
CD20 CD3 CD5 Cyclin-D1
MCL: Phenotype/Genotype
![Page 12: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/12.jpg)
In situ mantle cell neoplasia (ISMCN) Formerly: “In situ MCL”, MCLis
Rare (frequency <1%)
Low rate of progression
Avoid calling these lymphoma
Require clinical assessment
Not systematically diagnosed
Leukemic non-nodal MCL (15%)
PB, BM & spleen
No adenopathy
SOX11 -, IgH mutated
Clinically indolent (may transform to aggressive disease)
MCL, classical-type Lymph nodes & extranodal sites
SOX11 +, IgH unmutated
Mantle cell lymphoma (MCL)
Adam et al. Mod Pathol 2012
![Page 13: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/13.jpg)
A lymphoma of germinal center B-cells (centrocytes &
centroblasts) with at least a partially follicular pattern
Follicular lymphoma: Definition
![Page 14: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/14.jpg)
• Most common lymphoma worldwide (30%)
• Median age 55-59 yrs; male = female
• Generalized lymphadenopathy, Splenomegaly, BM
• Indolent clinical course, but: transformation & progression
• Follicular with diffuse areas
• Centroblast & centrocytes; FDC, reactive T-cells
• Grade 1 & 2 (low grade), 3A&B (high grade)
• Phenotype: CD19, CD20; CD10, BCL6, HGAL, LMO2; BCL2
• Genotype: IgH rearranged, t(14;18) and IgH/BCL2
FL - major features
![Page 15: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/15.jpg)
• B-cell markers: CD19, CD20, PAX5, CD79A
• GC-markers: BCL6, CD10, Stathmin, HGAL, GCET1, LMO2
Phenotype of FL
Appl Immunhistochem Mol Morphol 2015
![Page 16: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/16.jpg)
• Clonal IgH rearrangement
• Somatic hypermutation in variable regions (ongoing)
• Intraclonal variation
• t14;18 (IgH/BCL2): 90% (ambiguous protein
expression)
• BCL6 rearranged: 15%
• MYC rearranged: rare (2-4%)
• Recurrent mutations: KMT2D, CREBBP, EZH2, BCL2
Genotype of FL
Leich et al. Leukemia 2016
Miao et al. Human Pathol 2017
![Page 17: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/17.jpg)
![Page 18: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/18.jpg)
• In situ follicular neoplasia (ISFN)
• Duodenal-type FL
• Diffuse-appearing FL with del1p36
• Extranodal FL
• Pediatric-type FL
FL variants & related lymphomas
![Page 19: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/19.jpg)
• Formerly: “in-situ Follicular lymphoma”, FLis
• Indolent clonal population
• High frequency (2-3% of “patients”)
• Low rate of progression
• Avoid calling these “lymphoma”
• Require clinical assessment
• Not systematically diagnosed
In situ follicular neoplasia (ISFN)
Xerri, Dirnhofer et al.
Virchow, 2016
Am J Surg Pathol 2016
![Page 20: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/20.jpg)
• Variant of FL
• Different from generic GI-tract FL
• Low grade (G1)
• BCL2 positive (t14;18 positive)
• Excellent prognosis
• Avoid overtreatment
• Watch-and-wait strategy ?
Duodenal-type FL
Schmatz et al., JCO 2011
![Page 21: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/21.jpg)
• Pediatric FL a provisional entity in 2008 monograph
• Promoted to definite entity
• Name change & refined criteria
• Can occur in (young) adults
• Large expansile follicles, Grade 3, high Ki-67
• BCL2 negative (t14;18 negative)
• Head & neck
• Excellent prognosis (only excision)
• DD: FL, Grade 3, conventional type
Pediatric-type FL
Quintanilla-Martinez et al.
Virchow, 2016
2016
![Page 22: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/22.jpg)
FL with conventional morphology
50-70% express BCL2, often CD10 negative
No clinical impact
Diffuse variant of FL with deletion 1p36
Grade 1‐2
Large nodal mass in inguinal region, localized
Deletion 1p36
Good prognosis
Primary extranodal FL
Cutaneous
Pediatric-type FL
Promoted to definite entity
LBCL with IRF4-rearrangement
Provisional entity
Different subtypes of t(14;18) negative FL
Leich et al. Blood 2009
Leich et al. Leukemia 2016
Katzenberger et al. Blood 2009
Höller et al. Human Pathol 2012
![Page 23: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/23.jpg)
Grading of FL
Jaffe E., Hematopatholoy 2017
WHO 2017
An excisional biopsy is
recommended for primary diagnosis.
![Page 24: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/24.jpg)
DLBCL FL IIIb
FL IIIa FL II FL I
Grading of FL
![Page 25: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/25.jpg)
Survival of patients with FL according to histological grade
Weisenburger et al. 2006; from: Jaffe et al, Hematopathology 2017
![Page 26: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/26.jpg)
Transformation
• Occurs in many types of small B-cell lymphomas
• Most common in FL (2-3% per yr)
• Broad morphologic spectrum
• Mechanisms of transformation (in FL)
• Divergent evolution from common progenitor cell (CPC)
• Linear evolution
• High-level CNA
• Recurrent mutations in TP53,
MYC, CDKN2A, B2M …
Okosun et al, Nat Gen 2014
Schmidt et al, Leukemia 2014
Brunner et al, Leukemia 2014
Wagner-Johnston et al, Blood 2015
Casulo et al, Blood 2015
Agbay et al, Am J Surg Pathol 2016
Bouska et al, Leukemia 2017
Kridel et al, PLOS Medicine 2017
Kridel et al, Blood 2017 from: Pasqualucci et al, Cell 2014
![Page 27: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/27.jpg)
tFL: Histotypes
• DLBCL, incl. DLBCL CD30+
• HGBCL, NOS (former BCL,u)
• HGBCL with double-hit (BCL2/MYC)
• Lymphoblastic Lymphoma (TdT+; CD34+)
• cHL
• Histiocytic Sarcoma
• DD: true composite lymphoma
2016
![Page 28: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/28.jpg)
Thank you!
![Page 29: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/29.jpg)
• Most common B-cell lymphoma
• Clinicopathological variants in updated WHO-classification
• Advanced stage, indolent course
• Grade 1 & 2; 3A & 3B
• Grading is mandatory (and prognostic), cave CNB
• Recurrent genetic alteration t14;18 (BCL/IgH) in 85%
• No clinical difference of t14;18-negative cases
• Transformation common (2-3%/yr)
• tFL: DLBCL, HGBCL-DH/TH, HGBCL-NOS, PBL, cHL, HS
“The Pathobiology of FL” - Summary
![Page 30: Low-grade B-cell lymphoma · 2018. 9. 12. · aggressive vs indolent ... Agbay et al, Am J Surg Pathol 2016 Bouska et al, Leukemia 2017 Kridel et al, PLOS Medicine 2017 Kridel et](https://reader036.vdocuments.us/reader036/viewer/2022071302/60aa64370246845c554b8d92/html5/thumbnails/30.jpg)
Am J Surg Pathol 2005